← Open Payments lookup

XIAOYANG MEI: Open Payments

NPI 1871214676 · FLUSHING, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,811 in 85 payments from 10 companies in 2025. Trend: 2023 $3,196 · 2024 $3,939 · 2025 $3,811

Food & beverage: $3,710Education: $101
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$750
Teva Pharmaceuticals USA, Inc.16$602
ABBVIE INC.7$595
Alkermes, Inc.14$525
Axsome Therapeutics, Inc.7$466
E.R. Squibb & Sons, L.L.C.10$327
Otsuka America Pharmaceutical, Inc.5$294
Neurocrine BioSciences, Inc.1$124
Takeda Pharmaceuticals U.S.A., Inc.4$113
Supernus Pharmaceuticals, Inc.1$17

Products named: CAPLYTA, VRAYLAR, Auvelity, UZEDY, COBENFY, REXULTI, ARISTADA, LYBALVI.

Industry payments across NY — which companies pay providers there.